EUVIMEDEUVIMED entdecken
Scoping Review

A scoping review of the clinical utility of adverse drug reaction causality analysis tools for use in the hospital setting

Benjamin Deutscher iD, Keshia De Guzman, Adam La Caze, Nazanin Falconer

Expert Review of Clinical Pharmacology · 2024

DOI: 10.1080/17512433.2024.2429677 ↗

Kurz gefasst

Scoping Review in der Zeitschrift Expert Review of Clinical Pharmacology, 2024. Verfasst von Benjamin Deutscher und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, University of Queensland, Ipswich, Queensland, Australia. Hauptthemen laut MEDLINE: Drug-Related Side Effects and Adverse Reactions, Adverse Drug Reaction Reporting Systems. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 73 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: Identification and monitoring of adverse drug reactions (ADRs) and interventions to reduce ADRs are essential for patient safety in hospitals. Causality analysis (CA) is an approach that helps to determine a causal link between medication and patient harm (i.e. an ADR). While numerous CA tools exist, there is no gold standard. AREAS COVERED: Five online databases were searched to identify studies that evaluated the potential clinical utility of CA tools for ADRs. CA tools were mapped against the Bradford Hill (BH) criteria and included if they adhered to the first seven criteria proposed by BH. Upon the database search, 550 studies were identified, with 41 studies being selected that looked at tools mapped to BH. Thirty-four different CA tools were identified in the included studies. EXPERT OPINION: Naranjo and WHO-UMC were the most reported CA tools for studies examining inter-rater and intra-rater reliability. Naranjo commonly received a 'fair' agreement level while WHO-UMC received a 'substantial' agreement level between raters. Along with kappa statistics, time using the CA tool was also analyzed, with WHO-UMC being the most time-efficient. There does not appear to be one CA tool that can be applied universally to pharmacovigilance efforts in hospital in-patient settings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug-Related Side Effects and Adverse ReactionsAdverse Drug Reaction Reporting SystemsHumansHospitalsPatient SafetyDatabases, FactualReproducibility of ResultsPharmacovigilance

Stichwörter der Autor:innen

Adverse drug reactionadverse drug eventcausality analysisinter-raterintra-rater reliabilitymedication harm

Autor:innen und Institutionen

  • School of Pharmacy, University of Queensland, Ipswich, Queensland, Australia.

ORCID-Profile: Benjamin Deutscher

Zitieren

APA

Deutscher, B., De Guzman, K., La Caze, A., & Falconer, N. (2024). A scoping review of the clinical utility of adverse drug reaction causality analysis tools for use in the hospital setting. Expert Review of Clinical Pharmacology. https://doi.org/10.1080/17512433.2024.2429677

Vancouver

Deutscher B, De Guzman K, La Caze A, Falconer N. A scoping review of the clinical utility of adverse drug reaction causality analysis tools for use in the hospital setting. Expert Review of Clinical Pharmacology. 2024. doi:10.1080/17512433.2024.2429677

BibTeX
@article{Deutscher2024,
  author = {Deutscher, Benjamin and De Guzman, Keshia and La Caze, Adam and Falconer, Nazanin},
  title = {A scoping review of the clinical utility of adverse drug reaction causality analysis tools for use in the hospital setting},
  journal = {Expert Review of Clinical Pharmacology},
  year = {2024},
  doi = {10.1080/17512433.2024.2429677}
}
Kostenlos starten →